Hoey Investments’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98K Hold
1,000
﹤0.01% 310
2026
Q1
$1.34K Hold
1,000
﹤0.01% 348
2025
Q4
$2.45K Hold
1,000
﹤0.01% 338
2025
Q3
$6.71K Hold
1,000
﹤0.01% 270
2025
Q2
$5.88K Hold
1,000
﹤0.01% 266
2025
Q1
$8.39K Hold
1,000
﹤0.01% 219
2024
Q4
$7.44K Hold
1,000
﹤0.01% 223
2024
Q3
$6.65K Hold
1,000
﹤0.01% 231
2024
Q2
$6.65K Hold
1,000
﹤0.01% 231
2024
Q1
$13.1K Hold
1,000
﹤0.01% 200
2023
Q4
$12.8K Hold
1,000
﹤0.01% 194
2023
Q3
$13.1K Buy
+1,000
New +$18.3K ﹤0.01% 191

Other funds holding TMCI

Hoey Investments's TMCI Position: Q2 2026 in Review

Hoey Investments held its Treace Medical Concepts (TMCI) position steady in Q2 2026 at 1,000 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #310.

Hoey Investments first reported a position in TMCI in Q3 2023 and has held it in 12 quarters since. The position peaked at $13.1K in Q3 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Hoey Investments held 1,000 shares of Treace Medical Concepts worth $3.98K as of Q2 2026.
  • Hoey Investments left its Treace Medical Concepts share count unchanged in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #310 holding.
  • Hoey Investments first reported a position in Treace Medical Concepts in Q3 2023 and has held it in 12 quarters since.
  • Hoey Investments's Treace Medical Concepts position peaked at $13.1K in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.